nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2020, 21, v.26 1630-1634
温阳降浊通络法中药治疗阴阳两虚兼血瘀证糖尿病肾病的临床疗效观察
基金项目(Foundation): 辽宁省科技厅重点研发项目(2018225042)~~
邮箱(Email):
DOI: 10.13210/j.cnki.jhmu.20200424.004
发布时间: 2020-04-24
出版时间: 2020-04-24
网络发布时间: 2020-04-24
移动端阅读
摘要:

目的:观察温阳降浊通络法中药治疗阴阳两虚兼血瘀证糖尿病肾病患者的临床疗效及其对血清炎症因子的影响。方法:将76例阴阳两虚兼血瘀证糖尿病肾病患者随机分为观察组和对照组,每组各38例。对照组给予控制体质量、控制血糖、控制血压、纠正脂代谢紊乱等西医常规治疗,观察组则在西医常规治疗基础上加服温阳降浊通络法中药,两组疗程均为1个月。观察两组治疗前后中医证候积分、肾功能指标[血肌酐(Scr)、血尿素氮(BUN)、尿微量白蛋白(MALB)]、糖代谢指标[空腹血糖(FPG)、餐后2 h血糖(2 hPG)、糖化血红蛋白(HbA1c)]、血液流变学指标[血浆黏度(PV)、血小板聚集率(PAR)、纤维蛋白原(FIB)]、胱抑素-C(Cys-C)、C反应蛋白(CRP)的变化情况。结果:治疗后,观察组的临床疗效明显优于对照组(P<0.05),两组中医证候积分、肾功能指标(Scr、BUN、UAER)、糖代谢指标(FPG、2 hPG、HbAlc)、血液流变学指标(PV、PAR、FIB)、Cys-C、CRP均较治疗前明显下降,差异具有统计学意义(P<0.05);且观察组上述各项指标的下降作用明显优于对照组,差异具有统计学意义(P<0.05)。结论:温阳降浊通络法中药治疗阴阳两虚兼血瘀证糖尿病肾病患者,具有较好临床疗效,可有效改善临床症状、糖代谢、肾功能以及微循环障碍,其机制可能与减轻微炎症状态有关。

Abstract:

Objective: To observe the clinical efficacy of compound of "warming yang, descending turbidity and dredging collaterals" in the treatment of diabetic kidney disease with yin-yang deficiency and blood stasis syndrome. Methods: Seventy-six patients of diabetic kidney disease with yin-yang deficiency and blood stasis syndrome were randomly divided into the observation group and the control group, with thirty-eight cases in each group. The control group was given conventional western medicine treatment, while the observation group took compound of "warming yang, descending turbidity and dredging collaterals" orally on the basis of conventional western medicine treatment. The course of treatment covered for one month. Before and after the treatment, we observed the scores of traditional Chinese medicine symptoms, indicators of renal function [serum creatinine(Scr), blood urea nitrogen(BUN), microalbuminuria(MALB)], indicators of glucose metabolism [fasting plasma glucose(FPG), 2-hour postprandial blood glucose(2 hPG), glycosylated hemoglobin(HbAlc)], indicators of hemorheology[plasma viscosity(PV), platelet aggregation rate(PAR), fibrinogen(FIB)], Cystatin-C(Cys-C), C-reactive protein(CRP) in the two groups. Results: After treatment, the clinical effect of the observation group was significantly better than the control group(P<0.05). The scores of traditional Chinese medicine symptoms, indicators of renal function(Scr, BUN, UAER), indicators of glucose metabolism(FPG, 2 hPG, HbAlc), indicators of hemorheology(PV, PAR, FIB), Cys-C and CRP in the two groups were decreased significantly compared with those before treatment(P<0.05), and the decrease in the observation group was superior to that in the control group(P<0.05). Conclusion: Compound of "warming yang, descending turbidity and dredging collaterals" has remarkable efficacy in treating of diabetic kidney disease patients with yin-yang deficiency and blood stasis syndrome by alleviating clinical symptoms, glucose metabolism, renal function and microcirculatory disturbance, and the mechanism related to alleviation of micro-inflammation.

参考文献

1 桑小溪.糖尿病肾病发病机制的研究进展[J].当代医学,2019,25(17):193-194.

2 Doshi SM,Friedman AN.Diagnosis and management of type 2 diabetic kidney disease[J].Clin J Am Soc Nephrol,2017,12(8):1366-1373.

3 Aghadavod E,Khodadadi S,Baradaran A,et al.Role of oxidative stress and inflammatory factors in diabetic kidney disease[J].Iran J Kidney Dis,2016,10(6):337-343.

4 Andrade Lopes S,Jornayvaz FR,De Seigneux S.Chronic kidney disease and new antidiabetic drugs :an overview in 2019[J].Rev Med Suisse,2019,15(653):1106-1111.

5 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018,38(4):292-344.

6 中华医学会糖尿病学分会微血管并发症学组.糖尿病肾病防治专家共识(2014年版)[J].中华糖尿病杂志,2014,6(11):792-801.

7 中华中医药学会.糖尿病肾病中医防治指南[J].中国中医药现代远程教育,2011,9(4):151-153.

8 中华中医药学会肾病分会.糖尿病肾病诊断、辨证分型及疗效评定标准(试行方案)[J].上海中医药杂志,2007,41(7):7-8.

9 中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:129-134,181-182.

10 Sharma D,Bhattacharya P,Kalia K,et al.Diabetic nephropathy:New insights into established therapeutic paradigms and novel molecular targets[J].Diabetes Res Clin Pract,2017,128:91-108.

11 孙晓泽,谭高峰,刘爱华.消渴方加减对气阴两虚夹瘀型糖尿病肾病的内皮损伤、氧化应激及生化指标的影响[J].中国实验方剂学杂志,2019,25(9):43-48.

12 楚淑芳,赵恒侠,刘德亮,等.滋肾降糖丸联合西药治疗气阴两虚证糖尿病肾病(G3aA2期)的临床观察及对Galectin-3的影响[J].广州中医药大学学报,2019,36(8):1126-1132.

13 杨柳,李爱平,张王宁,等.黄芪及含黄芪经方在治疗肾病方面的药理作用及临床应用研究进展[J].中草药,2018,49(14):3419-3424.

14 赵锦,陈玮,魏杰,等.淫羊藿苷对糖尿病肾病大鼠肾功能的保护作用及相关机制[J].免疫学杂志,2020,36(1):74-79.

15 刘嫱,房磊臣,韦祎,等.益智仁提取物对糖尿病肾病模型小鼠的疗效及机制研究[J].中国医药导报,2015,12(33):21-25.

16 韦袆,谢毅强,罗嘉莉,等.南药益智仁对糖尿病肾病氧化应激iNOS及PARLmRNA表达的影响[J].中国医药导刊,2018,20(12):752-755.

17 高子涵,李瑞芳,吕行直,等.山药多糖对糖尿病肾病小鼠肾功能和醛糖还原酶通路的影响[J].中药材,2019,42(3):643-646.

18 彭静.黄精皂苷对糖尿病肾病大鼠肾损伤的保护作用及Wnt/β-catenin信号通路的影响[J].中成药,2019,41(10):2518-2521.

19 杨晓曦,程晓晨,卢育新,等.芡实醇提物对糖尿病肾病大鼠肾功能的影响及其体外抗氧化能力测定[J].国际药学研究杂志,2015,42(3):380-385.

20 王硕朋,姚源璋,盖丰丰,等.泽兰水提物调节PKC同工酶治疗早期糖尿病肾病的研究[J].中医药导报,2019,25(13):22-25.

21 许强,文豪,李修身,等.丹参酮ⅡA磺酸钠治疗糖尿病肾病的Meta分析[J].中药新药与临床药理,2020,31(1):113-119.

22 王新苗,杨浩宇,顾成娟,等.黄芪、水蛭粉、大黄治疗糖尿病肾病经验—仝小林三味小方撷萃[J].吉林中医药,2020,40(1):5-7.

23 窦晨辉,陈晓虎,彭书玲.益气养阴通络方对早期糖尿病肾病微炎症状态的影响[J].南京中医药大学学报,2019,35(2):144-147.

24 王绪山,李静,王敏,等.NLR和CRP对早期糖尿病肾病的诊断意义[J].国际检验医学杂志,2019,40(2):230-233.

基本信息:

DOI:10.13210/j.cnki.jhmu.20200424.004

中图分类号:R259;R277.5

引用信息:

[1]詹立北,熊晓东,赵凯.温阳降浊通络法中药治疗阴阳两虚兼血瘀证糖尿病肾病的临床疗效观察[J].海南医学院学报,2020,26(21):1630-1634.DOI:10.13210/j.cnki.jhmu.20200424.004.

基金信息:

辽宁省科技厅重点研发项目(2018225042)~~

发布时间:

2020-04-24

出版时间:

2020-04-24

网络发布时间:

2020-04-24

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文